Citrobacter freundii
General medical information for education only, not medical advice. Treatment considerations summarize published guidance at drug-class level; therapy is chosen by the treating clinician using susceptibility results, local resistance patterns and current guidelines.
Overview
A gut and environmental Gram-negative rod causing opportunistic infection.
Infections
Urinary tract infection, intra-abdominal infection, bloodstream infection; neonatal meningitis is described with other Citrobacter species.
Signs and symptoms
Urinary infection, the most common presentation: painful urination, frequency, urgency, cloudy or foul-smelling urine, flank pain or fever. Wound and intra-abdominal infection: pain, swelling and fever. Bloodstream infection: fever and chills.
Antibiotic and antimicrobial resistance
Chromosomal AmpC (AmpC); can acquire carbapenemases (carbapenemases).
Treatment considerations
Guided by susceptibility testing. C. freundii carries an inducible chromosomal AmpC, so third-generation cephalosporins can fail during treatment; IDSA guidance suggests cefepime for serious infection, with a carbapenem when cefepime is not suitable.

Sources
- CDC. Healthcare-associated infections: diseases and organisms.
- CDC. ESBL-producing Enterobacterales.
- CDC. Carbapenem-resistant Enterobacterales (CRE).
- IDSA. Guidance on the Treatment of Antimicrobial-Resistant Gram-Negative Infections.
- IDSA. Complicated Urinary Tract Infections guideline.
Sources accessed November 2026. Links open external sites that InnovexLab does not control.
Medical disclaimer
This page is general educational information summarized from published public-health and professional-society guidance. It is not medical advice, a diagnosis or a treatment recommendation, and reading it does not create a clinician–patient relationship with InnovexLab. Decisions about testing, diagnosis and treatment belong to the treating clinician, using the patient’s history and examination, laboratory and susceptibility results, local resistance patterns and current guidelines. Guidance changes over time; consult the original sources for the latest version. InnovexLab provides this information as is and does not warrant that it is complete or current.
Patients with questions about their health should contact their own healthcare provider. In an emergency, call 911.